Emilie Laprévotte

841 total citations
13 papers, 648 citations indexed

About

Emilie Laprévotte is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, Emilie Laprévotte has authored 13 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 5 papers in Genetics and 4 papers in Oncology. Recurrent topics in Emilie Laprévotte's work include Chronic Lymphocytic Leukemia Research (5 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (3 papers). Emilie Laprévotte is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Immune Cell Function and Interaction (4 papers) and Immunotherapy and Immune Responses (3 papers). Emilie Laprévotte collaborates with scholars based in France, Switzerland and United Kingdom. Emilie Laprévotte's co-authors include Nathalie Bonnefoy, Laurent Gros, Jérôme Giustiniani, Jean‐François Eliaou, Armand Bensussan, Stéphanie Cochaud, Gilles Alberici, Jérémy Bastid, Henri‐Alexandre Michaud and Virginie Lafont and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Emilie Laprévotte

13 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emilie Laprévotte France	9	347	283	188	116	109	13	648
Sabrina Bossio Italy	11	292 0.8×	251 0.9×	207 1.1×	74 0.6×	72 0.7×	30	601
Céline Rodriguez France	8	220 0.6×	195 0.7×	134 0.7×	77 0.7×	17 0.2×	14	489
Philip Hicks United States	9	171 0.5×	287 1.0×	276 1.5×	128 1.1×	40 0.4×	12	597
Lai Chun Ong Singapore	5	173 0.5×	297 1.0×	171 0.9×	100 0.9×	9 0.1×	5	546
Lauryn R. Werner United States	9	161 0.5×	263 0.9×	176 0.9×	75 0.6×	16 0.1×	19	475
P. Anoop Chandran Germany	9	126 0.4×	82 0.3×	351 1.9×	317 2.7×	91 0.8×	12	619
Hussein Shehade United States	7	193 0.6×	172 0.6×	92 0.5×	85 0.7×	21 0.2×	10	378
Rana Baraz Australia	10	185 0.5×	174 0.6×	227 1.2×	32 0.3×	18 0.2×	13	559
Lelisa Gemta United States	6	394 1.1×	315 1.1×	212 1.1×	165 1.4×	10 0.1×	6	657

Countries citing papers authored by Emilie Laprévotte

Since Specialization

Citations

This map shows the geographic impact of Emilie Laprévotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilie Laprévotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilie Laprévotte more than expected).

Fields of papers citing papers by Emilie Laprévotte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emilie Laprévotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilie Laprévotte. The network helps show where Emilie Laprévotte may publish in the future.

Co-authorship network of co-authors of Emilie Laprévotte

This figure shows the co-authorship network connecting the top 25 collaborators of Emilie Laprévotte. A scholar is included among the top collaborators of Emilie Laprévotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emilie Laprévotte. Emilie Laprévotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Laprévotte, Emilie, Aurélie Docquier, Jérémy Bastid, et al.. (2017). Abstract 1602: Generation of anti-IL-17B antibodies neutralizing IL-17B-mediated alterations of the immune microenvironment, promotion of tumor cell initiating capacity and chemoresistance. Cancer Research. 77(13_Supplement). 1602–1602. 1 indexed citations

Laprévotte, Emilie, Stéphanie Cochaud, Stanislas du Manoir, et al.. (2017). The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway. Oncotarget. 8(69). 113360–113372. 41 indexed citations

Cochaud, Stéphanie, Yacine Merrouche, Christian Garbar, et al.. (2015). IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells. Scientific Reports. 5(1). 11874–11874. 48 indexed citations

Laprévotte, Emilie, Jérémy Bastid, Stéphanie Cochaud, et al.. (2015). Abstract 5027: Interleukin-17B promotes chemoresistance of breast tumors through ERK1/2 anti-apoptotic pathway. Cancer Research. 75(15_Supplement). 5027–5027. 4 indexed citations

Bastid, Jérémy, Nathalie Bonnefoy, Cécile Déjou, et al.. (2014). Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity. Cancer Immunology Research. 3(3). 254–265. 172 indexed citations

Lafont, Virginie, et al.. (2014). Plasticity of Î³Î´ T Cells: Impact on the Anti-Tumor Response. Frontiers in Immunology. 5. 622–622. 110 indexed citations

Cochaud, Stéphanie, Jérôme Giustiniani, Clémence Thomas, et al.. (2013). IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2. Scientific Reports. 3(1). 3456–3456. 113 indexed citations

Laprévotte, Emilie, Grégory Voisin, Loïc Ysebaert, et al.. (2013). Recombinant Human IL-15 Trans-Presentation by B Leukemic Cells from Chronic Lymphocytic Leukemia Induces Autologous NK Cell Proliferation Leading to Improved Anti-CD20 Immunotherapy. The Journal of Immunology. 191(7). 3634–3640. 28 indexed citations

Laprévotte, Emilie, Loïc Ysebaert, Christian Klein, et al.. (2012). Endogenous IL-8 acts as a CD16 co-activator for natural killer-mediated anti-CD20 B cell depletion in chronic lymphocytic leukemia. Leukemia Research. 37(4). 440–446. 15 indexed citations

10.

Laprévotte, Emilie, Emilie‐Fleur Gautier, Cathy Quelen, et al.. (2012). Specific small nucleolar RNA expression profiles in acute leukemia. Leukemia. 26(9). 2052–2060. 103 indexed citations

11.

Ysebaert, Loïc, Emilie Laprévotte, Christian Klein, et al.. (2011). “Don't Eat me”: CD47 and LFA-1 Modulate CLL Response to Nurselike Cells-Mediated Antibody-Dependent Phagocytosis Induced by Rituximab and Obinutuzumab (GA101). Blood. 118(21). 1762–1762. 1 indexed citations

12.

Capietto, Aude-Hélène, Emilie Gross, Nicolas Dauguet, et al.. (2010). Emerging Concepts for the Treatment of Hematological Malignancies with Therapeutic Monoclonal Antibodies. Current Drug Targets. 11(7). 790–800. 9 indexed citations

13.

Ysebaert, Loïc, Emilie Laprévotte, Christian Klein, et al.. (2010). Clinical and Biological Characteristics Associated with In Vitro Activity of Anti-CD20 Monoclonal Antibodies, Rituximab and GA101, Against Chronic Lymphocytic Leukemia Cells. Blood. 116(21). 2459–2459. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact